Worldwide, over 694 million people have been infected with SARS-CoV-2, with an estimated
55–60% of those infected develo** COVID-19. Since the beginning of the pandemic in …

Answer questions and earn CME/CNE Colorectal cancer (CRC) is the third most common
cancer and third leading cause of cancer death in both men and women and second leading …

COVID survivors frequently experience lingering neurological symptoms that resemble
cancer-therapy-related cognitive impairment, a syndrome for which white matter microglial …

Background Up to 60% of breast cancer patients treated with chemotherapy is confronted
with cognitive problems, which can have a significant impact on daily activities and quality of …

After advanced age, female sex is the major risk factor for late-onset Alzheimer's disease
(AD), the most common cause of dementia affecting over 24 million people worldwide. The …

Brain metastases occur commonly in patients with advanced solid malignancies. Yet, less is
known about brain metastases than cancer-related entities of similar incidence. Advances in …

One in three people will be diagnosed with cancer during their lifetime. The community of
cancer patients is growing, and several common cancers are becoming increasingly …

Purpose After cancer treatment, it is desirable to maintain or regain a high quality of life
(QoL) and the ability to accomplish everyday tasks well. Therefore, we substantiated the …

Background Chemotherapy-related cognitive impairment (CRCI) is highly prevalent in
patients with cancer and is associated with poor outcomes and quality of life. To date, the …

Cancer-related cognitive impairment (CRCI) is commonly experienced by individuals with
non-central nervous system cancers throughout the disease and treatment trajectory. CRCI …